{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:31:23Z","timestamp":1773685883935,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11102-025-01604-2","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T08:27:25Z","timestamp":1765182445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-5683","authenticated-orcid":false,"given":"Busra F\u0131rlatan","family":"Yazgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9644-5981","authenticated-orcid":false,"given":"Selin","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6740-6708","authenticated-orcid":false,"given":"S\u00fcleyman Nahit","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-944X","authenticated-orcid":false,"given":"Seda Hanife","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-1750","authenticated-orcid":false,"given":"Selcuk","family":"Dagdelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-9394","authenticated-orcid":false,"given":"Tomris","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"8","key":"1604_CR1","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1016\/s0022-5347(01)61691-4","volume":"83","author":"SM Orme","year":"1998","unstructured":"Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab 83(8):2730\u20132734. https:\/\/doi.org\/10.1016\/s0022-5347(01)61691-4","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1604_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/erc-16-0106","volume":"23","author":"E Ritvonen","year":"2016","unstructured":"Ritvonen E, L\u00f6yttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P et al (2016) Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer 23(6):469\u2013480. https:\/\/doi.org\/10.1530\/erc-16-0106","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"1604_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood.v80.6.1443.1443","volume":"80","author":"WJ Murphy","year":"1992","unstructured":"Murphy WJ, Tsarfaty G, Longo DL (1992) Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood 80(6):1443\u20131447. https:\/\/doi.org\/10.1182\/blood.v80.6.1443.1443","journal-title":"Blood"},{"issue":"13","key":"1604_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1182\/blood.v80.6.1443.1443","volume":"22","author":"G Tsarfaty","year":"1994","unstructured":"Tsarfaty G, Longo DL, Murphy WJ (1994) Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration. Exp Hematol 22(13):1273\u20131277. https:\/\/doi.org\/10.1182\/blood.v80.6.1443.1443","journal-title":"Exp Hematol"},{"issue":"8","key":"1604_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1634\/stemcells.2004-0322","volume":"23","author":"MB Hanley","year":"2005","unstructured":"Hanley MB, Napolitano LA, McCune JM (2005) Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells 23(8):1170\u20131179. https:\/\/doi.org\/10.1634\/stemcells.2004-0322","journal-title":"Stem Cells"},{"issue":"5","key":"1604_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/bf03344122","volume":"29","author":"S Bergamaschi","year":"2006","unstructured":"Bergamaschi S, Giavoli C, Ferrante E, Lania A, Rusconi R, Spada A et al (2006) Growth hormone replacement therapy in growth hormone deficient children and adults: effects on hemochrome. J Endocrinol Invest 29(5):399\u2013404. https:\/\/doi.org\/10.1007\/bf03344122","journal-title":"J Endocrinol Invest"},{"key":"1604_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ghir.2018.07.005","volume":"42","author":"A Ciresi","year":"2018","unstructured":"Ciresi A, Piazza G, Radellini S, Guarnotta V, Mineo MG, Giordano C (2018) Growth hormone and hematopoiesis: a retrospective analysis on a large cohort of children with growth hormone deficiency. Growth Horm IGF Res 42:8\u201313. https:\/\/doi.org\/10.1016\/j.ghir.2018.07.005","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"1604_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1203\/00006450-199412000-00011","volume":"36","author":"R Anttila","year":"1994","unstructured":"Anttila R, Koistinen R, Sepp\u00e4l\u00e4 M, Koistinen H, Siimes MA (1994) Insulin-like growth factor I and insulin-like growth factor binding protein 3 as determinants of blood hemoglobin concentration in healthy subjects. Pediatr Res 36(6):745\u2013748. https:\/\/doi.org\/10.1203\/00006450-199412000-00011","journal-title":"Pediatr Res"},{"issue":"2","key":"1604_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1160\/th10-06-0379","volume":"105","author":"E Succurro","year":"2011","unstructured":"Succurro E, Arturi F, Caruso V, Rudi S, Sciacqua A, Andreozzi F et al (2011) Low insulin-like growth factor-1 levels are associated with anaemia in adult non-diabetic subjects. Thromb Haemost 105(2):365\u2013370. https:\/\/doi.org\/10.1160\/th10-06-0379","journal-title":"Thromb Haemost"},{"issue":"11","key":"1604_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.4158\/ep14100.or","volume":"21","author":"F De Vita","year":"2015","unstructured":"De Vita F, Maggio M, Lauretani F, Crucitti L, Bandinelli S, Mammarella F et al (2015) Insulin-like growth factor-1 and anemia in older subjects: the Inchianti study. Endocr Pract 21(11):1211\u20131218. https:\/\/doi.org\/10.4158\/ep14100.or","journal-title":"Endocr Pract"},{"issue":"5","key":"1604_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.7326\/0003-4819-124-5-199603010-00006","volume":"124","author":"P Grellier","year":"1996","unstructured":"Grellier P, Chanson P, Casadevall N, Abboud S, Schaison G (1996) Remission of polycythemia vera after surgical cure of acromegaly. Ann Intern Med 124(5):495\u2013496. https:\/\/doi.org\/10.7326\/0003-4819-124-5-199603010-00006","journal-title":"Ann Intern Med"},{"issue":"2","key":"1604_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11102-011-0311-6","volume":"15","author":"G Zoppoli","year":"2012","unstructured":"Zoppoli G, Bianchi F, Bruzzone A, Calvia A, Oneto C, Passalia C et al (2012) Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. Pituitary 15(2):209\u2013214. https:\/\/doi.org\/10.1007\/s11102-011-0311-6","journal-title":"Pituitary"},{"key":"1604_CR13","doi-asserted-by":"publisher","unstructured":"Aguiar DPC, Nesello AC, Araujo B, dos Santos TM, Lima VD, Lima JFSP et al (2025) Anemia in patients with pituitary adenomas: prevalence and correlation with hypopituitarism. Cureus 17(6). https:\/\/doi.org\/10.7759\/cureus.85422","DOI":"10.7759\/cureus.85422"},{"key":"1604_CR14","unstructured":"Geneva S, World Health Organization (2011) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system. Document Reference WHO"},{"issue":"9","key":"1604_CR15","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","volume":"10","author":"WM Gardner","year":"2023","unstructured":"Gardner WM, Razo C, McHugh TA, Hagins H, Vilchis-Tella VM, Hennessy C et al (2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990\u20132021: findings from the global burden of disease study 2021. Lancet Haematol 10(9):e713\u2013e34. https:\/\/doi.org\/10.1016\/S2352-3026(23)00160-6","journal-title":"Lancet Haematol"},{"issue":"2","key":"1604_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.hoc.2015.11.002","volume":"30","author":"GA Collaborators","year":"2016","unstructured":"Collaborators GA (2016) The global burden of anemia. Hematol Oncol Clin N Am 30(2):247\u2013308. https:\/\/doi.org\/10.1016\/j.hoc.2015.11.002","journal-title":"Hematol Oncol Clin N Am"},{"issue":"5","key":"1604_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2013-06-508325","volume":"123","author":"NJ Kassebaum","year":"2014","unstructured":"Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R et al (2014) A systematic analysis of global anemia burden from 1990 to 2010. Blood 123(5):615\u2013624. https:\/\/doi.org\/10.1182\/blood-2013-06-508325","journal-title":"Blood"},{"key":"1604_CR18","unstructured":"World Health Organization (\u200e2015)\u200e. The global prevalence of anaemia in 2011. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/177094"},{"issue":"3","key":"1604_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1210\/jcem.81.3.8772595","volume":"81","author":"AS Bates","year":"1996","unstructured":"Bates AS, Van\u2019t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81(3):1169\u20131172. https:\/\/doi.org\/10.1210\/jcem.81.3.8772595","journal-title":"J Clin Endocrinol Metab"},{"key":"1604_CR20","first-page":"1","volume-title":"Williams Hematology","author":"XT Gregg","year":"2015","unstructured":"Gregg XT (2015) Erythropoietic effects of endocrine disorders. In: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ (eds) Williams Hematology, McGraw-Hill Education, New York, 9e page (1-10).","edition":"9e"},{"key":"1604_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11102-010-0251-6","volume":"14","author":"I Shimon","year":"2011","unstructured":"Shimon I, Benbassat C, Tzvetov G, Grozinsky-Glasberg S (2011) Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression. Pituitary 14:11\u201315. https:\/\/doi.org\/10.1007\/s11102-010-0251-6","journal-title":"Pituitary"},{"issue":"10","key":"1604_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.40030","volume":"6","author":"KM Pencina","year":"2023","unstructured":"Pencina KM, Travison TG, Artz AS, Lincoff AM, Nissen SE, Flevaris P et al (2023) Efficacy of testosterone replacement therapy in correcting anemia in men with hypogonadism: a randomized clinical trial. JAMA Netw Open 6(10):e2340030\u2013e. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.40030","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1604_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/gerona\/glt154","volume":"69","author":"E Bachman","year":"2014","unstructured":"Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M et al (2014) Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point. J Gerontol A Biol Sci Med Sci 69(6):725\u2013735. https:\/\/doi.org\/10.1093\/gerona\/glt154","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"1604_CR24","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1210\/jc.2007-1692","volume":"93","author":"AD Coviello","year":"2008","unstructured":"Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S (2008) Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 93(3):914\u2013919. https:\/\/doi.org\/10.1210\/jc.2007-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"1604_CR25","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3171\/jns.2003.98.5.0974","volume":"98","author":"DB Ellegala","year":"2003","unstructured":"Ellegala DB, Alden TD, Couture DE, Vance ML, Maartens NF, Laws ER Jr (2003) Anemia, testosterone, and pituitaryadenoma in men. J Neurosurg 98:974\u2013977. https:\/\/doi.org\/10.3171\/jns.2003.98.5.0974","journal-title":"J Neurosurg"},{"issue":"1","key":"1604_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1749-6632.1968.tb15168.x","volume":"149","author":"SJ Piliero","year":"1968","unstructured":"Piliero SJ, Medici PT, Haber C (1968) The interrelationships of the endocrine and erythropoietic systems in the rat with special reference to the mechanism of action of estradiol and testosterone. Ann N Y Acad Sci 149(1):336\u2013355. https:\/\/doi.org\/10.1111\/j.1749-6632.1968.tb15168.x","journal-title":"Ann N Y Acad Sci"},{"issue":"7484","key":"1604_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nature12932","volume":"505","author":"D Nakada","year":"2014","unstructured":"Nakada D, Oguro H, Levi BP, Ryan N, Kitano A, Saitoh Y et al (2014) Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature 505(7484):555\u2013558. https:\/\/doi.org\/10.1038\/nature12932","journal-title":"Nature"},{"issue":"2","key":"1604_CR28","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.1210\/clinem\/dgab674","volume":"107","author":"NA van Vliet","year":"2022","unstructured":"van Vliet NA, Kamphuis AE, den Elzen WP, Blauw GJ, Gussekloo J, Noordam R et al (2022) Thyroid function and risk of anemia: a multivariable-adjusted and Mendelian randomization analysis in the UK biobank. J Clin Endocrinol Metabolism 107(2):e643\u2013e52. https:\/\/doi.org\/10.1210\/clinem\/dgab674","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1604_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/2230-8210.122635","volume":"88","author":"TS Ashraf","year":"2017","unstructured":"Ashraf TS, De Sanctis V, Yassin M, Wagdy M, Soliman N (2017) Chronic anemia and thyroid function. Acta Bio Medica: Atenei Parmensis 88(1):119. https:\/\/doi.org\/10.4103\/2230-8210.122635","journal-title":"Acta Bio Medica: Atenei Parmensis"},{"issue":"5","key":"1604_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.20452\/pamw.3985","volume":"127","author":"E Szczepanek-Parulska","year":"2017","unstructured":"Szczepanek-Parulska E, Hernik A, Rucha\u0142a M (2017) Anemia in thyroid diseases. Pol Arch Intern Med 127(5):352\u2013360. https:\/\/doi.org\/10.20452\/pamw.3985","journal-title":"Pol Arch Intern Med"},{"issue":"2","key":"1604_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1210\/jcem-40-2-211","volume":"40","author":"KC Das","year":"1975","unstructured":"Das KC, Mukherjee M, Sarkar TK, Dash RJ, Rastogi GK (1975) Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 40(2):211\u2013220. https:\/\/doi.org\/10.1210\/jcem-40-2-211","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1604_CR32","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4158\/ep.4.5.279","volume":"71","author":"U Pl\u00f6ckinger","year":"1990","unstructured":"Pl\u00f6ckinger U, Dienemann D, Quabbe HJ (1990) Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. J Clin Endocrinol Metab 71(6):1658\u20131662. https:\/\/doi.org\/10.4158\/ep.4.5.279","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"1604_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.mce.2007.11.024","volume":"286","author":"A Ben-Shlomo","year":"2008","unstructured":"Ben-Shlomo A, Melmed S (2008) Somatostatin agonists for treatment of acromegaly. Mol Cell Endocrinol 286(1\u20132):192\u2013198. https:\/\/doi.org\/10.1016\/j.mce.2007.11.024","journal-title":"Mol Cell Endocrinol"},{"issue":"8 Suppl 1","key":"1604_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0026-0495(96)90087-6","volume":"45","author":"I Lancranjan","year":"1996","unstructured":"Lancranjan I, Bruns C, Grass P, Jaquet P, Jervell J, Kendall-Taylor P et al (1996) Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism 45(8 Suppl 1):67\u201371. https:\/\/doi.org\/10.1016\/s0026-0495(96)90087-6","journal-title":"Metabolism"},{"issue":"1","key":"1604_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1210\/jcem.82.1.3572","volume":"82","author":"AK Fl\u00f8gstad","year":"1997","unstructured":"Fl\u00f8gstad AK, Halse J, Bakke S, Lancranjan I, Marbach P, Bruns C et al (1997) Sandostatin LAR in acromegalic patients: long-term treatment. J Clin Endocrinol Metab 82(1):23\u201328. https:\/\/doi.org\/10.1210\/jcem.82.1.3572","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1604_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/erc-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M et al (2017) Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database. Endocr Relat Cancer 24(10):505\u2013518. https:\/\/doi.org\/10.1530\/erc-17-0253","journal-title":"Endocr Relat Cancer"},{"key":"1604_CR37","doi-asserted-by":"publisher","first-page":"788247","DOI":"10.3389\/fendo.2021.788247","volume":"12","author":"A Krygier","year":"2022","unstructured":"Krygier A, Szczepanek-Parulska E, Cie\u015blewicz M, Wrotkowska E, Chanaj-Kaczmarek et al (2022) Iron homeostasis and Hepcidin concentration in patients with acromegaly. Front Endocrinol 12:788247. https:\/\/doi.org\/10.3389\/fendo.2021.788247","journal-title":"Front Endocrinol"},{"key":"1604_CR38","doi-asserted-by":"publisher","first-page":"1559S","DOI":"10.3945\/ajcn.117.155804","volume":"106","author":"GJ Anderson","year":"2017","unstructured":"Anderson GJ, Frazer DM (2017) Current understanding of iron homeostasis. Am J Clin Nutr 106:1559S\u20131566S. https:\/\/doi.org\/10.3945\/ajcn.117.155804","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"1604_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094591","volume":"22","author":"ACS Vogt","year":"2021","unstructured":"Vogt ACS, Arsiwala T, Mohsen M, Vogel M, Manolova V, Bachmann MF (2021) On iron metabolism and its regulation. Int J Mol Sci 22(9):4591. https:\/\/doi.org\/10.3390\/ijms22094591","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1604_CR40","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/eje-16-0178","volume":"175","author":"CL Boguszewski","year":"2016","unstructured":"Boguszewski CL, Ayuk J, MANAGEMENT OF ENDOCRINE, DISEASE (2016) Acromegaly and cancer: an old debate revisited. Eur J Endocrinol 175(4):R147\u2013R156. https:\/\/doi.org\/10.1530\/eje-16-0178","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1604_CR41","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1210\/jc.2017-02457","volume":"103","author":"J Dal","year":"2018","unstructured":"Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C et al (2018) Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab 103(6):2182\u20132188. https:\/\/doi.org\/10.1210\/jc.2017-02457","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1604_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12020-022-03282-7","volume":"80","author":"SH Oguz","year":"2023","unstructured":"Oguz SH, Firlatan B, Sendur SN, Dagdelen S, Erbas T (2023) Follow, consider, and catch: second primary tumors in acromegaly patients. Endocrine 80(1):160\u2013173. https:\/\/doi.org\/10.1007\/s12020-022-03282-7","journal-title":"Endocrine"},{"issue":"4","key":"1604_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","volume":"17","author":"S Dagdelen","year":"2014","unstructured":"Dagdelen S, Cinar N, Erbas T (2014) Increased thyroid cancer risk in acromegaly. Pituitary 17(4):299\u2013306. https:\/\/doi.org\/10.1007\/s11102-013-0501-5","journal-title":"Pituitary"},{"issue":"2","key":"1604_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1172\/jci116621","volume":"92","author":"R Clark","year":"1993","unstructured":"Clark R, Strasser J, McCabe S, Robbins K, Jardieu P (1993) Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest 92(2):540\u2013548. https:\/\/doi.org\/10.1172\/jci116621","journal-title":"J Clin Invest"},{"issue":"6","key":"1604_CR45","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1182\/blood.v88.6.2250.bloodjournal8862250","volume":"88","author":"P Georgii-Hemming","year":"1996","unstructured":"Georgii-Hemming P, Wiklund HJ, Ljunggren O, Nilsson K (1996) Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood 88(6):2250\u20132258. https:\/\/doi.org\/10.1182\/blood.v88.6.2250.bloodjournal8862250","journal-title":"Blood"},{"issue":"4","key":"1604_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11102-009-0176-0","volume":"14","author":"FR Barbosa","year":"2011","unstructured":"Barbosa FR, Vieira Neto L, Lima GA, Wildemberg LE, Portugal R, Gadelha MR (2011) Hematologic neoplasias and acromegaly. Pituitary 14(4):377\u2013381. https:\/\/doi.org\/10.1007\/s11102-009-0176-0","journal-title":"Pituitary"},{"issue":"4","key":"1604_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11102-009-0176-0","volume":"49","author":"V Popovic","year":"1998","unstructured":"Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M et al (1998) Increased incidence of neoplasia in patients with pituitary adenomas. The pituitary study group. Clin Endocrinol (Oxf) 49(4):441\u2013445. https:\/\/doi.org\/10.1007\/s11102-009-0176-0","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1604_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4158\/ep.4.5.279","volume":"4","author":"RH Alves","year":"1998","unstructured":"Alves RH, Vaisman M, Brasil RR, Gadelha MR (1998) Acromegaly and non-Hodgkin\u2019s lymphoma. Endocr Pract 4(5):279\u2013281. https:\/\/doi.org\/10.4158\/ep.4.5.279","journal-title":"Endocr Pract"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01604-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:38:08Z","timestamp":1773682688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01604-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1604"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01604-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}